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G protein-coupled receptor (GPCR)2 signaling is, in part,
tightly regulated by the availability of the receptors on the cell
surface (1). In general, upon agonist stimulation, GPCRs initiate signaling by coupling to heterotrimeric G proteins at the
plasma membrane (2). Prolonged agonist stimulation often
leads to receptor phosphorylation by GPCR kinases, ␤-arrestin
recruitment, and receptor internalization via ␤-arrestin-mediated interaction with clathrin-coated pits (3, 4). Once a GPCR is
internalized, it either recycles back to the plasma membrane or
is sorted for degradation via the endosome-lysosome pathway
(5).
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It was traditionally thought that acute G protein-mediated
signaling terminated once the receptor was phosphorylated
and bound ␤-arrestin and that the receptor could only fully
resume its ability to activate G protein signaling once it was
internalized, dephosphorylated, and recycled back to the
plasma membrane (1). However, it has been recently appreciated that activated GPCRs, such as the ␤2-adrenergic receptor
(␤2AR) (6) and thyroid-stimulating hormone receptor (7, 8),
can also mediate acute G protein-dependent signaling on endosomes (9).
Recently, ␣-arrestins, a subgroup of the arrestin clan that also
includes visual-/␤-arrestins and VPS26-related proteins, have
been suggested to regulate cell surface transporter and GPCR
endocytic trafficking (5). For example, yeast ␣-arrestins serve as
adaptor proteins for E3 ubiquitin ligases and regulate cell surface transporter degradation in response to stress (10, 11). In
mammals, there are six ␣-arrestins, named arrestin-domain
containing protein (ARRDC) 1–5 and thioredoxin-interacting
protein. Sequence comparison suggests the following two fundamental differences between mammalian ␣-arrestins and visual-/␤-arrestins that could potentially functionally differentiate
these two subclans in cells: 1) ␣-arrestins appear to lack a “polar
core” (12) that functions in maintaining visual-/␤-arrestins in
their “basal conformation” and is crucial for their phosphosensing activity (13); and 2) most ␣-arrestins contain PPXY
motifs in their C-tails that visual-/␤-arrestins lack (11, 12, 14).
PPXY motifs often interact with WW-domains, and ARRDCs
have been shown to interact with the WW-domain of various
HECT-domain E3 ubiquitin ligases (15–17). Indeed, the first
PPXY motif of ARRDC3 has been shown to interact with the
third WW domain of Nedd4 with high affinity in vitro (18).
Mutations of either the PPXY motifs of ARRDC3 or WW
domains of Nedd4 inhibit the interaction between these two
proteins in cells (15, 18).
Recently, a role for ARRDC3 in ␤2AR endocytic trafficking
has been proposed. Nabhan et al. (15) reported that ARRDC3
primarily acts at the plasma membrane where it interacts with
the ␤2AR in an agonist-dependent manner and functions to
facilitate Nedd4-mediated ubiquitination and subsequent degradation of the ␤2AR. In contrast, Han et al. (19) showed that
overexpression or depletion of ARRDC3 does not affect ␤2AR
ubiquitination, internalization, or degradation. In fact, their
VOLUME 291 • NUMBER 28 • JULY 8, 2016
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Arrestin domain-containing protein 3 (ARRDC3) is a member of the mammalian ␣-arrestin family, which is predicted to
share similar tertiary structure with visual-/␤-arrestins and also
contains C-terminal PPXY motifs that mediate interaction with
E3 ubiquitin ligases. Recently, ARRDC3 has been proposed to
play a role in regulating the trafficking of G protein-coupled
receptors, although mechanistic insight into this process is lacking. Here, we focused on characterizing the role of ARRDC3 in
regulating the trafficking of the ␤2-adrenergic receptor (␤2AR).
We find that ARRDC3 primarily localizes to EEA1-positive early
endosomes and directly interacts with the ␤2AR in a ligand-independent manner. Although ARRDC3 has no effect on ␤2AR
endocytosis or degradation, it negatively regulates ␤2AR entry
into SNX27-occupied endosomal tubules. This results in
delayed recycling of the receptor and a concomitant increase in
␤2AR-dependent endosomal signaling. Thus, ARRDC3 functions as a switch to modulate the endosomal residence time and
subsequent intracellular signaling of the ␤2AR.

ARRDC3 Regulates ␤2AR Recycling and Signaling

Results
ARRDC3 Is Localized on EEA1-positive Early Endosomes and
Interacts with the ESCRT-0 Complex—To evaluate the cellular
localization of ARRDC3, we initially transfected GFP-tagged
wild type ARRDC3 or a GFP-tagged PPXY mutant ARRDC3
(ARRDC3-AASA/AALA) in HEK293 cells. Using fixed cell immunofluorescence microscopy, we found that ARRDC3 is
mainly localized to endocytic vesicles, although ARRDC3AASA/AALA is primarily at the plasma membrane (Fig. 1A).
Using EEA1, LAMP1, and giantin antibody staining as early
endosome, late endosome/lysosome, and trans-Golgi network
markers, respectively, we found that ARRDC3 mainly co-localized with EEA1 on EEA1-positive early endosomes (Fig. 1B). To
assess the localization of endogenous ARRDC3, we co-immunostained ARRDC3 and EEA1/LAMP1 in BT549 cells, a breast
cancer cell line that has a 5–10-fold higher expression level of
endogenous ARRDC3 compared with HEK293 cells (Fig. 1, C
and D). Importantly, endogenous ARRDC3 co-localized with
EEA1 in BT549 cells, although the staining was lost by treatment with an ARRDC3-specific siRNAs that effectively knocked
down expression (Fig. 1D). There was no apparent co-localization
of ARRDC3 with LAMP1 in these cells. Thus, ARRDC3 is primarily localized on EEA1-positive early endosomes.
To further evaluate the endosomal localization of ARRDC3,
we co-expressed FLAG-tagged STAM-1, a component of the
ESCRT-0 complex that primarily localizes to early endosomes
(20), and HA-tagged ARRDC3 in HEK293 cells. Immunoprecipitation studies showed that ARRDC3 co-immunoprecipitates with STAM-1 (Fig. 2A). In contrast, ARRDC3-AASA/
AALA, which is primarily localized at the plasma membrane,
did not co-immunoprecipitate with STAM-1 (Fig. 2A). Because
the ESCRT-0 complex has been reported to localize to discrete microdomains of EEA1-positive early endosomes (21), we
hypothesized that ARRDC3 would localize to the same
microdomains as STAM-1. To better visualize early endosomes,
we transiently transfected HEK293 cells with Rab5Q79L, a Rab5
mutant that enhances homotypic early endosome fusion and
JULY 8, 2016 • VOLUME 291 • NUMBER 28

results in enlarged early endosomes (22). Immunofluorescence
microscopy and associated line scan analysis demonstrated that
ARRDC3 and endogenous STAM co-localized to the same
early endosome microdomains (Fig. 2B). Taken together, we
conclude that ARRDC3 interacts with the ESCRT-0 complex
on EEA1-positive early endosomes.
One PPXY Motif Is Needed to Localize ARRDC3 to
Endosomes—Because ARRDC3-AASA/AALA was primarily
localized at the plasma membrane, we next determined
whether both PPXY motifs are required to localize ARRDC3 to
endosomes. Both GFP-tagged ARRDC3-AASA and ARRDC3AALA showed strong endosomal localization similar to wild
type ARRDC3 (Fig. 2C), suggesting that one PPXY motif is sufficient to mediate ARRDC3 localization to early endosomes.
We also tested whether the C-tail of ARRDC3, which contains
both PPXY motifs, is sufficient for endosomal localization. The
GFP-tagged ARRDC3 C-tail was primarily cytoplasmic with a
localization pattern similar to GFP alone (Fig. 2C). This suggests that the arrestin-like domain of ARRDC3 is also important for the endosomal localization of ARRDC3.
Because ARRDC3 interacts with Nedd4 family ubiquitin
ligases via its PPXY motifs (15, 18, 19), we tested whether
ARRDC3 was ubiquitinated and, if so, whether the ubiquitination status of ARRDC3 played a role in its localization. We
monitored the ubiquitination status of transfected GFP-tagged
wild type and mutant ARRDC3 by immunoprecipitating
ARRDC3 and blotting for endogenous ubiquitin. Although
ARRDC3 was clearly ubiquitinated, ARRDC3-AASA/AALA appeared to undergo no ubiquitination. Moreover, both
ARRDC3-AASA and ARRDC3-AALA were also ubiquitinated,
although ARRDC3-AASA appeared to undergo less ubiquitination (Fig. 2D). These observations demonstrate that only one of
the PPXY motifs is needed to facilitate ARRDC3 ubiquitination.
Taken together, we conclude that at least one PPXY motif as
well as the arrestin-like domain are required to mediate
ARRDC3 localization to endosomes. Although the endosomal
localization of ARRDC3 is positively correlated with its ubiquitination state, we do not know whether ubiquitination is
required for endosomal localization.
ARRDC3 Interacts with the ␤2AR in a Ligand-independent
Manner—To evaluate whether ARRDC3 interacts with the
␤2AR, we transiently co-transfected FLAG-tagged ␤2AR with
either HA-tagged ARRDC3 or HA-tagged ␤-arrestin2 in
HEK293 cells. The cells were treated with or without agonist
and lysed, and then FLAG-␤2AR was immunoprecipitated and
analyzed for co-immunoprecipitation of ARRDC3 or ␤-arrestin2. As expected, ␤-arrestin2 co-immunoprecipitation with
the ␤2AR was markedly increased by agonist treatment (Fig.
3A). ARRDC3 also co-immunoprecipitated with the ␤2AR,
although the degree of interaction was not affected by isoproterenol (ISO) (Fig. 3A). These observations were confirmed
using a bioluminescence resonance energy transfer (BRET)
assay, which monitors protein-protein interaction in living cells
(23). Upon ISO stimulation, the BRET ratio of ␤2AR-RlucII and
GFP10-␤-arrestin2 rapidly increased over the 30-min time
course (Fig. 3B). In contrast, the BRET ratio of ␤2AR-RlucII and
GFP10-ARRDC3 was high at time 0 and was largely unaffected
by the addition of isoproterenol (Fig. 3B). This suggests that the
JOURNAL OF BIOLOGICAL CHEMISTRY
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study suggested that the ARRDC3 siRNA used by Nabhan et al.
(15) could also knockdown ␤-arrestin expression and that it
was ␤-arrestin that mediated ␤2AR ubiquitination and degradation, and not ARRDC3. They also demonstrated that endosomal localized ARRDC3 co-localized with internalized ␤2AR.
Although these findings are intriguing, it is evident that the role
of ARRDCs in ␤2AR trafficking, if any, has not been clearly
defined.
In this study, we investigated the role of ARRDC3 in ␤2AR
trafficking by evaluating the following: 1) the cellular localization of ARRDC3; 2) ARRDC3 interaction with the ␤2AR; and 3)
the role of ARRDC3 in ␤2AR endocytic trafficking and endosomal signaling. We find that ARRDC3 is mainly localized to
EEA1-positive early endosomes, where it interacts with the
ESCRT-0 complex. ARRDC3 associates with the ␤2AR in a
ligand-independent manner and regulates ␤2AR recycling by
negatively regulating ␤2AR entry into recycling tubules,
thereby retaining it on EEA1-positive early endosomes. Consequently, ARRDC3 modulates receptor-dependent G protein
signaling on endosomes.

ARRDC3 Regulates ␤2AR Recycling and Signaling

␤2AR and ARRDC3 interact in an agonist-independent manner. We also treated cells expressing the ␤2AR-RlucII and
GFP10-ARRDC3 with the ␤2AR inverse agonists, propranolol
and ICI 118,551, and again found no effect on the BRET ratio
(Fig. 3C). To verify that this was a true measure of ␤2ARARRDC3 interaction, we performed a bystander BRET analysis
by varying the ratio of GFP10-ARRDC3 to ␤2AR-RlucII.
Indeed, the BRET ratio increased hyperbolically as a function of
increasing GFP10/RlucII ratio, and saturation was reached
indicating that all ␤2AR-RlucII was associated with GFP10ARRDC3 (Fig. 3D). These results support the conclusion that
the high BRET ratio between the ␤2AR-RlucII and GFP10ARRDC3 is indeed a result of protein-protein interaction. To

14512 JOURNAL OF BIOLOGICAL CHEMISTRY

further support these results, we performed an in vitro pulldown assay using purified FLAG-tagged ␤2AR in the presence
or absence of ISO or propranolol along with in vitro translated
35
S-labeled ARRDC3. ARRDC3 was able to bind to the ␤2AR,
and this binding was unaffected by ligand (Fig. 3E). Taken
together, our data demonstrate that ARRDC3 directly interacts
with the ␤2AR in a ligand-independent manner.
It was noticeable that a higher BRET ratio was observed at
time 0 in ␤2AR-RlucII and GFP10-ARRDC3 co-transfected
cells (Fig. 2B), suggesting some association between these proteins under steady state. Because the ␤2AR is primarily localized to the plasma membrane while ARRDC3 is at the endosome in unstimulated cells (Fig. 1A), it was puzzling how
VOLUME 291 • NUMBER 28 • JULY 8, 2016
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FIGURE 1. ARRDC3 is primarily localized to EEA1-positive early endosomes. A, representative immunofluorescence images show the localization of
transiently transfected pEGFP-ARRDC3 and pEGFP-AASA/AALA in HEK293 cells (from n ⬎5). B, representative immunofluorescence images and co-localization
analyses of transiently transfected pEGFP-ARRDC3 (shown in green) with endocytic markers (shown in red) in HEK293 cells. n ⫽ 25. Data points are represented
as mean, min to max. C, Western blot analysis evaluating the expression level of endogenous ARRDC3 and effectiveness of siRNA knockdown in HEK293 and
BT549 cells. 50 g of whole cell lysate was loaded in each lane. D, representative immunofluorescence images and co-localization analyses demonstrating the
co-localization of endogenous ARRDC3 (shown in green) and EEA1/LAMP1 (shown in red) in BT549 cells. Western blotting is used to evaluate the degree of
endogenous ARRDC3 depletion by siRNA. n ⫽ 25. Data points are represented as mean, min to max. Scale bars, 5 m. IB, immunoblot.
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FIGURE 2. ARRDC3 is ubiquitinated and interacts with the ESCRT-0 complex. A, co-immunoprecipitation of transiently transfected pEGFP-ARRDC3 or
pEGFP-ARRDC3-AASA/AALA with FLAG-STAM-1 in HEK293 cells. B, representative immunofluorescence images and corresponding line scan analysis demonstrating the co-localization of expressed pEGFP-ARRDC3 and endogenous STAM on endosomes in HEK293 cells. Endosomes were enlarged by transient
transfection of Rab5-Q79L. Scale bars of the insets, 1 m. C, top, representative immunofluorescence images are shown to demonstrate the localization of WT
and mutant pEGFP-ARRDC3 in HEK293 cells. Middle and bottom, same cells were co-stained for endogenous STAM to evaluate the co-localization with the
ESCRT-0 complex. D, ubiquitination of WT and mutant GFP-ARRDC3 was evaluated by immunoprecipitating ARRDC3 followed by detection of endogenous
ubiquitin by Western blotting. All experiments are done at least three times. Scale bars, 5 m. WCL, whole cell lysate; IB, immunoblot.

ARRDC3 and ␤2AR would exhibit a significant BRET ratio
before receptor activation. To address this question, we transiently transfected pEGFP-ARRDC3 in HEK293 cells stably
expressing FLAG-tagged ␤2AR (24). The cells were fixed, perJULY 8, 2016 • VOLUME 291 • NUMBER 28

meabilized, and then immunostained with FLAG antibody to
visualize the ␤2AR. Surprisingly, in GFP-ARRDC3-expressing
cells, a noticeable endosomal co-localization of ␤2AR and
ARRDC3 was observed in unstimulated cells (Fig. 3F). This
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. ARRDC3 directly interacts with the ␤2AR in a ligand-independent manner. Co-immunoprecipitation (A) and BRET analysis (B) were performed
to assess the interaction of the ␤2AR and ARRDC3 using ␤-arrestin2 as a control. The increased ␤2AR expression level in ARRDC3 co-expressed samples shown
in A, 6th and 7th lanes, is not reproducible. Cells were treated ⫾10 M ISO for 25 min. Experiments were done at least three times. Representative data are
shown. C, BRET analysis was performed to evaluate the interaction of the ␤2AR and ARRDC3 upon treating cells with indicated ligands. BRET ratio was taken at
15 min. n ⫽ 3. Representative data are shown. Data are represented as mean ⫾ S.D. D, bystander BRET analysis with increased amounts of GFP10-ARRDC3 to
a fixed concentration of ␤2AR-RlucII. n ⫽ 3. Representative data are shown. Data are represented as mean ⫾ S.D. E, in vitro pulldown assay was performed to
assess the interaction of the purified ␤2AR and in vitro translated 35S-labeled ARRDC3. The ␤2AR was either unliganded or bound with ISO or propranolol. n ⫽
5. Representative data are shown. Data are represented as mean ⫾ S.E. F, representative fixed cell immunofluorescence images show the localization of the
␤2AR in FLAG-␤2AR-stable HEK293 cells transiently transfected with vector or pEGFP-ARRDC3. Scale bars, 5 m. WCL, whole cell lysate; IB, immunoblot.

likely explains the basal level of ␤2AR and ARRDC3 interaction
suggested by the high BRET ratio at time 0.
ARRDC3 Regulates ␤2AR Recycling—We next examined the
functional role of ARRDC3 in ␤2AR endocytic trafficking. We

14514 JOURNAL OF BIOLOGICAL CHEMISTRY

hypothesized that ARRDC3 would not affect ␤2AR internalization due to the endosomal localization of ARRDC3 (Fig. 1, A
and B). We transiently transfected either vector control or
ARRDC3 in a HEK293 cell line stably expressing FLAG-␤2AR
VOLUME 291 • NUMBER 28 • JULY 8, 2016
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FIGURE 4. ARRDC3 regulates agonist-induced ␤2AR recycling. A, rate of ␤2AR internalization was evaluated by cell surface ELISA. Cells were transiently
transfected with vector, ARRDC3, or ARRDC3-AASA/AALA in FLAG-␤2AR-stable HEK293 cells. n ⫽ 3. Data are represented as mean ⫾ S.D. B, immunofluorescence staining and co-localization of the ␤2AR and ARRDC3 or ARRDC3-AASA/AALA upon 20 min of treatment with 10 M ISO in FLAG-␤2AR-stable HEK293
cells. C, total amount of ␤2AR present in ␤2AR-stable HEK293 cells at each ISO-treated time point was assessed by [125I]iodocyanopindolol binding assay. The
graph represents the mean ⫾ S.D. from three independent experiments. D, immunofluorescence staining and co-localization analysis, demonstrated by
Pearson’s coefficient, of the ␤2AR, ARRDC3, and the lysosomal marker LAMP1, upon a 4-h treatment with 10 M ISO in ␤2AR-stable HEK293 cells. Representative
images are shown. Pearson’s coefficient is the mean ⫾ S.D. from n ⫽ 30. E, flow cytometric analysis of the ␤2AR recycling by uptake and efflux of cell
surface-labeled M1 anti-FLAG antibody in FLAG-␤2AR-stable HEK293 cells transiently transfected with vector, ARRDC3, or ARRDC3-AASA/AALA. The graph
represents the mean ⫾ S.D. from three independent experiments. F, representative immunofluorescence staining and co-localization of the ␤2AR and ARRDC3
or ARRDC3-AASA/AALA upon 20 min of treatment with 10 M ISO followed by a 30-min incubation with 10 M propranolol. G, flow cytometric analysis of ␤2AR
recycling by uptake and efflux of cell surface-labeled M1 anti-FLAG antibody in FLAG-␤2AR-stable HEK293 cells transfected with siControl or siARRDC3. The
graph represents the mean ⫾ S.D. from three independent experiments. Unpaired t test. H, quantitation of fluorescence changes of SpH-␤2AR demonstrating
a rapid loss of surface ␤2AR level in response to 10 M ISO treatment and recovery in response to washout with 10 M alprenolol in SpH-␤2AR-stable HEK293
cells transfected with siControl or siARRDC3. Fluorescence values were normalized to initial values from multiple cells (n ⬎1,500 cells analyzed). I, flow
cytometric analysis of TfR recycling by uptake and efflux of cell surface-labeled transferrin. The graph represents the mean ⫾ S.D. from three independent
experiments. Scale bars, 5 m.

and monitored the rate of agonist-promoted ␤2AR internalization using a cell surface ELISA (25). A similar rate of ␤2AR
internalization was observed in cells transfected with either
JULY 8, 2016 • VOLUME 291 • NUMBER 28

vector control, wild type ARRDC3, or ARRDC3-AASA/AALA
(Fig. 4A). These findings were also supported by fixed cell
immunostaining, which showed that cell surface ␤2ARs were
JOURNAL OF BIOLOGICAL CHEMISTRY
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role in ␤2AR recycling and does not broadly disrupt the recycling machinery.
ARRDC3 Promotes ␤2AR Retention on EEA1-positive
Endosomes by Negatively Regulating Tubule Entry—Because
ARRDC3 promoted the retention of ␤2ARs on endocytic vesicles (Fig. 4F), we further investigated the population of endosomes where the ␤2AR was localized. In ARRDC3-overexpressing cells, ␤2AR co-localized with ARRDC3 upon 20 min of ISO
stimulation followed by a 30-min agonist washout. Furthermore, ARRDC3 and the ␤2AR co-localized with EEA1 with little co-localization with LAMP1 or giantin (Fig. 5A). This demonstrates that ARRDC3 promotes the retention of ␤2AR on
EEA1-positive early endosomes.
␤2AR recycling is a highly regulated process. The basic
mechanism is thought to involve interaction of a C-terminal
PDZ-binding motif on the ␤2AR with the PDZ domain in
SNX27. SNX27 is associated with Vps26, a component of the
retromer complex, and mediates localization of the ␤2AR on
tubules (26). The internalized ␤2AR is recycled through these
EEA1-positive early endosomal tubules, which can be visualized in living cells (27). We hypothesized that ARRDC3 delays
␤2AR recycling by regulating ␤2AR entry into endosomal
tubules. To test this, we overexpressed GFP-ARRDC3 in the
stable ␤2AR HEK293 line, labeled the receptor with fluorescently conjugated FLAG antibody, stimulated cells with ISO for
10 min, and then collected Z-stack images of the cells. An
example of ␤2AR containing early endosomes with a recycling
tubule is shown (Fig. 5B). We sampled over 150 ␤2AR-containing endosomes with various levels of ARRDC3 (from 1 to ⬎20fold overexpression based on relative levels of GFP expression).
Interestingly, as the concentration of ARRDC3 on these
endosomes increased, the number of ␤2AR-containing endosomal tubules decreased (Fig. 5B). Importantly, this effect
was observed at relatively low levels of ARRDC3 expression
and was maximal at 4 – 8-fold overexpression. This suggests
that ARRDC3 negatively regulates ␤2AR entry into recycling
tubules.
Overexpression of ARRDC3 Decreases the Degree of Co-localization of ␤2AR and SNX27 on Endosomes—The ␤2AR contains
a PDZ-binding motif at the distal end of its C-tail (28, 29) that
interacts with the PDZ domain of SNX27, an interaction that is
crucial for ␤2AR recycling (30). In addition, interaction
between SNX27 and VPS26 on endosomes has been shown to
be critical for the recycling of PDZ-binding motif-containing
GPCRs (31, 32). We evaluated whether ARRDC3 plays a role in
regulating these two important protein-protein interactions by
analyzing the degree of co-localization of ␤2AR/SNX27 and
SNX27/VPS26 using fixed-cell confocal immunofluorescence
microscopy. After 20 min of ISO stimulation, the ␤2AR internalized and co-localized with SNX27 on endosomes (Fig. 6A,
top left). Agonist washout led to ␤2AR recycling and a decreased
level of co-localization with SNX27 over time. Interestingly, in
ARRDC3-overexpressing cells, significantly less co-localization
was observed between ␤2AR and SNX27 upon ISO stimulation
and washout (Fig. 6A), suggesting that ARRDC3 inhibits the
co-localization of ␤2AR and SNX27 on endosomes. In contrast,
ARRDC3 overexpression did not affect the degree of co-localization between SNX27 and VPS26 (Fig. 6B).
VOLUME 291 • NUMBER 28 • JULY 8, 2016
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comparably localized to endocytic vesicles in vector control,
ARRDC3, and ARRDC3-AASA/AALA transfected cells following 20 min of ISO treatment (Fig. 4B). Furthermore, knocking
down endogenous ARRDC3 using an ARRDC3-specific siRNA
also had no effect on the extent of agonist-promoted ␤2AR
internalization compared with control siRNA-treated cells
(data not shown) (19).
To evaluate whether ARRDC3 regulates agonist-promoted
␤2AR degradation, we analyzed ␤2AR levels using the radiolabeled antagonist [125I]iodocyanopindolol (25). We found that
ARRDC3 overexpression had no effect on ␤2AR degradation
over a 26-h time course (Fig. 4C). This was supported by fixedcell immunostaining, which revealed a minimal degree of agonist-promoted co-localization of ␤2AR and LAMP1 with or
without ARRDC3 overexpression following a 4-h agonist treatment (Fig. 4D). Thus, ARRDC3 does not appear to regulate
endocytosis or degradation of the ␤2AR.
We next transiently transfected ARRDC3 in the stable ␤2AR
cell line and used flow cytometric analysis (24) to evaluate
whether ARRDC3 affected the recycling of the internalized
␤2AR. As expected, the ␤2AR rapidly recycled back to the
plasma membrane in control cells, and this also occurred in
cells transfected with ARRDC3-AASA/AALA. However, the
rate and extent of ␤2AR recycling was significantly delayed in
cells overexpressing ARRDC3 (Fig. 4E). To further characterize
the potential effect of ARRDC3 on ␤2AR recycling, we used
fixed cell immunofluorescence microscopy. We found that the
␤2AR co-localized with ARRDC3 on endocytic vesicles after a
20-min treatment with ISO followed by a 30-min agonist washout (Fig. 4F). However, under the same conditions, the ␤2AR
had fully recycled back to the plasma membrane in both vector
control and ARRDC3-AASA/AALA-expressing cells (Fig. 4F).
Importantly, to assess whether endogenous ARRDC3 regulates
␤2AR recycling, we used the same flow cytometric analysis and
found that knocking down endogenous ARRDC3 resulted in a
significantly enhanced rate of ␤2AR recycling compared with
control siRNA-treated cells (Fig. 4G). In addition, we also
depleted endogenous ARRDC3 in an SpH-␤2AR-stable
HEK293 cell line and monitored the rate of ␤2AR recycling in
living cells. The SpH tag is pH-sensitive and only fluorescent in
a neutral pH, thus providing a way of monitoring cell surface
receptor levels. Indeed, depletion of endogenous ARRDC3
resulted in an enhanced rate of ␤2AR recycling compared
with control siRNA-treated cells (Fig. 4H). Taken together,
our results demonstrate that ARRDC3 regulates ␤2AR recycling but has no significant effect on ␤2AR endocytosis or
degradation.
We also addressed the question of whether ARRDC3 plays a
specific role in ␤2AR recycling or might more broadly regulate
endosomal recycling. For these studies, we transiently transfected vector or ARRDC3 in HEK293 cells and monitored
transferrin receptor (TfR) recycling. Similar to the ␤2AR, the
TfR recycles via early endosomes, although it is generally
viewed as utilizing a different pathway compared with the ␤2AR
(26). Our data show that ARRDC3 overexpression does not
alter the rate of TfR recycling compared with control transfected cells (Fig. 4I). This suggests that ARRDC3 plays a specific
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We also evaluated the localization of ␤2AR, ARRDC3, and
SNX27 on endosomes in living cells. After 10 min of ISO stimulation, cell surface-labeled and internalized ␤2AR could be
visualized on the body and tubule of enlarged and lumen-hollowed early endosomes. mApple-SNX27 was concentrated at
either the base of or on endosomal tubules and co-localized
with the ␤2AR (Fig. 6C). In contrast, in GFP-ARRDC3-expressing cells, the ␤2AR co-localized with ARRDC3 but did not colocalize with mApple-SNX27. Furthermore, although ␤2AR,
ARRDC3, and SNX27 could be visualized on the same endosomes, the ␤2AR-ARRDC3 complex was more prominently
localized to the endosomal body as opposed to a tubule, where
SNX27 mainly resided (Fig. 6C). Taken together, our data suggest that ARRDC3 interacts with the ␤2AR on endosomes and
inhibits receptor localization with SNX27 on endosomal
tubules.
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ARRDC3 Regulates ␤2AR Signaling on Endosomes—The concept of acute ␤2AR-dependent signal transduction on endosomes has been directly demonstrated recently (6). Because
ARRDC3 modulates the endosomal level of ␤2AR by regulating ␤2AR recycling, we tested whether ARRDC3 affected
acute ␤2AR-dependent signal transduction on endosomes.
Using a previously described luminescent-based assay to
monitor cAMP production in living cells in real time (33), we
found that the overall ␤2AR-dependent cAMP production
was increased in ARRDC3-expressing cells upon ISO stimulation, compared with control cells (Fig. 7A). To determine
whether this increase was due to cAMP production from
endosomes, the cells were treated with Dyngo-4a, a dynamin
inhibitor that blocks ␤2AR endocytosis (6), prior to ISO
stimulation. Dyngo-4a treatment resulted in an 11.4 ⫾ 1.9%
decrease in ISO-stimulated cAMP production in control
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. ARRDC3 retains the ␤2AR on EEA1-positive endosomes and negatively regulates ␤2AR tubule entry. A, representative images and corresponding quantifications of the co-localization of the ␤2AR, ARRDC3, and endocytic markers upon 20 min of treatment with 10 M ISO followed by 25 min of
treatment with 10 M propranolol. Unpaired t test. Pearson’s coefficients are the mean ⫾ S.E. from n ⫽ 30. B, representative ␤2AR-containing endosomes ⫾
tubules are shown. Percentages of total ␤2AR-containing endosomal tubules were assessed in cells with various levels of pEGFP-ARRDC3 expression (n ⫽
20 – 40 at each expression level). Scale bars, 5 m.
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FIGURE 6. Overexpression of ARRDC3 decreases the co-localization of the ␤2AR and SNX27 on endosomes. A, representative images and corresponding
quantifications of ␤2AR localization with endogenous SNX27 in cells with or without ARRDC3 overexpression were analyzed by immunofluorescence staining
upon 20 min of treatment with 10 M ISO followed by 10 M propranolol treatment for the indicated times. Three independent experiments were performed.
Pearson’s coefficients are the mean ⫾ S.E. and compared using an unpaired t test (n ⫽ 30). Scale bars, 5 m. B, representative images and corresponding
quantifications of the localization of endogenous SNX27 and VPS26 in cells with or without ARRDC3 overexpression were analyzed by immunofluorescence
staining upon 20 min of treatment with 10 M ISO followed by 10 M propranolol treatment for the indicated times. Three independent experiments were
performed. Pearson’s coefficients are the mean ⫾ S.E. and compared using an unpaired t test (n ⫽ 30). Scale bars, 5 m. C, representative immunofluorescence
confocal live cell images and corresponding line scan analysis are shown to demonstrate the localization of the ␤2AR, pEGFP-ARRDC3, and mApple-SNX27 on
the same endosomes. FLAG-␤2AR-stable HEK293 cells were transiently transfected with mApple-SNX27 and vector/pEGFP-ARRDC3. Three independent
experiments were performed, and over 50 endosomes were examined. Scale bars, 1 m.

cells suggesting some contribution of endosome-localized
activation of ␤2AR-mediated G␣s activity (Fig. 7, B–D) (6).
By comparison, there was a 32.4 ⫾ 3.3% decrease in cAMP
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production in ARRDC3-transfected cells upon Dyngo-4a
treatment, suggesting that ARRDC3 significantly enhances
the level of ␤2AR-mediated cAMP production on endosomes
VOLUME 291 • NUMBER 28 • JULY 8, 2016
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FIGURE 7. ARRDC3 modulates ␤2AR-dependent G␣s protein-mediated signal transduction on endosomes. A, forskolin-normalized ␤2AR-mediated cAMP
response in cells with or without ARRDC3 overexpression. More than six independent experiments were performed. Representative experimental data are
shown. B, forskolin-normalized ␤2AR-mediated cAMP response in the absence or presence of 30 M Dyngo-4a in cells with or without ARRDC3 expression. Four
independent experiments were performed. Representative experimental data are shown. C, average of 10 consecutive maximum values of each condition in
B. The graph represents the mean ⫾ S.E. from four independent experiments. Unpaired t test. D, calculated by using numerical values from C. % of inhibition ⫽
(1 ⫺ (maximum value of control or ARRDC3 ⫹ Dyngo/maximum value of control or ARRDC3)) ⫻ 100. The graph represents the mean ⫾ S.E. from the four
independent experiments in C. Unpaired t test. E, representative confocal live cell images and co-localization analysis of HEK293 cells overexpressing pEGFPARRDC3 and Nb37-mApple. Cells were stimulated with 10 M ISO for 20 min. n ⫽ 11. F, fluorescent intensity of Nb37-mApple on ␤2AR-occupied early
endosomes in the presence or absence of pEGFP-ARRDC3. The graph represents the mean ⫾ S.E. from ⬎50 endosomes for each condition. Unpaired t test.

(Fig. 7, B–D). Furthermore, we monitored the recruitment of
mApple-Nb37, a nanobody biosensor that recognizes the
catalytic intermediate of G␣s protein activation (6), and we
JULY 8, 2016 • VOLUME 291 • NUMBER 28

found that ARRDC3 expression significantly enhances the
level of active G␣s on endosomes compared with control
cells (Fig. 7, E and F). Taken together, we conclude that
JOURNAL OF BIOLOGICAL CHEMISTRY
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ARRDC3 regulates acute ␤2AR-dependent G␣s-mediated
cAMP production on endosomes.

Discussion
We show that ARRDC3 is primarily localized to EEA1-positive early endosomes, where it interacts with STAM-1, a component of the ESCRT-0 complex. Functionally, ARRDC3
retains internalized ␤2ARs on EEA1-positive early endosomes
and delays ␤2AR recycling by directly interacting with the
receptor and preventing it from associating with SNX27-occupied endosomal recycling tubules. This results in ARRDC3
modulation of ␤2AR-dependent G␣s-mediated cAMP production on endosomes (Fig. 8).
Although previous studies suggested that ARRDC3 localizes
to both the plasma membrane and endocytic vesicles, these
observations were made in heterologous cell lines overexpressing ARRDC3 (15, 19, 34, 35). Using fixed-cell confocal immunofluorescence microscopy, we demonstrated that both overexpressed (Fig. 1B) and endogenous (Fig. 1D) ARRDC3 are
primarily localized to EEA1-positive early endosomes. Plasma
membrane-localized ARRDC3 was only detected when pEGFPARRDC3 was highly overexpressed (data not shown), and no
endogenous ARRDC3 was detected at the plasma membrane of
BT549 cells (Fig. 1D). Although our studies suggest that
ARRDC3 is primarily localized at EEA1-positive early endosomes in HEK293 and BT549 cells, it’s worth noting that Dores
et al. (35) found that overexpressed ARRDC3 was equally distributed on both early and late endosomes in HeLa cells. Thus,
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it appears that the cellular localization of ARRDC3 is dependent on both the cell type and expression level.
Previous studies, as well as our own, show that ARRDC3 is
mainly localized to the plasma membrane when both PPXY
motifs of ARRDC3 are mutated to AAXA (15, 19) (Fig. 1A),
although we found that only a single PPXY motif is necessary
for endosomal localization (Fig. 2C). We further found that the
C-tail of ARRDC3 alone did not exhibit any specific localization
to cellular compartments (Fig. 2C), suggesting that the PPXY
motifs and arrestin domains of ARRDC3 are necessary to localize it to EEA1-positive early endosomes. Recently, the crystal
structure of the N-domain of ARRDC3 has been solved (36).
Interestingly, the residues on the concave surface of the N-domain are highly basic and were bound to phosphate ions in the
crystal. These basic residues might interact with phosphoinositides, such as phosphatidylinositol 4,5-bisphosphate and
phosphatidylinositol 3-phosphate, present on the plasma membrane and endosomal membrane, respectively, thus facilitating
ARRDC3 localization to membranes. Another potential contributor to ARRDC3 localization is ubiquitination because the
ubiquitination state of ARRDC3 correlates with its endosomal
localization (Fig. 2D). The observation that ARRDC3 is ubiquitinated was not surprising because it interacts with the
HECT-domain E3 ubiquitin ligases via its PPXY motifs (15,
18, 19). Interestingly, although ARRDC3 interacts with the
ESCRT-0 complex on EEA1-positive early endosomes (19),
ARRDC3-AASA/AALA does not. Because both HRS and
STAM contain ubiquitin-interacting motifs (20), it is possible
VOLUME 291 • NUMBER 28 • JULY 8, 2016
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FIGURE 8. Model of ARRDC3 regulation of ␤2AR trafficking and endosomal signaling. ARRDC3 is primarily localized to EEA1-positive early endosomes,
where it interacts with the ESCRT-0 complex. When ARRDC3 is not present, internalized ␤2AR interacts with SNX27 on early endosomes and undergoes rapid
recycling. When ARRDC3 is present on endosomes, it associates with the internalized ␤2AR, retains it on early endosomes, and delays ␤2AR recycling by
inhibiting its entry into SNX27-occupied endosomal recycling tubules. In turn, ARRDC3 modulates ␤2AR-dependent G␣s-mediated cAMP production on
endosomes.
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Recently, SNX27 as well as the retromer complex have been
shown to regulate the recycling of PDZ-binding motif-containing GPCRs (31, 32). Because ARRDC3 regulates ␤2AR recycling
by directly interacting with the ␤2AR and possibly modulating
the association of SNX27 with the PDZ-binding motif on the
C-tail of the ␤2AR (30), it is possible that interaction between
ARRDC3 and other GPCRs may play a broad role in regulating
receptor sorting.
Once the interaction between the ␤2AR and SNX27 is disrupted, the ␤2AR is degraded via the endosome-lysosome pathway instead of recycling back to the plasma membrane (30).
Interestingly, although our data suggest that ARRDC3 prevents
the interaction between the ␤2AR and SNX27 (Fig. 6), the rate
of ␤2AR degradation was unaffected by ARRDC3 (Fig. 4, C and
D). It is possible that ARRDC3 also influences receptor association with the ESCRT complex, thus “retaining” the ␤2AR on
endosomes. Furthermore, because ␤2AR degradation is influenced by its ubiquitination state, which is mediated by ␤-arrestin interaction with Nedd4 (39 – 41), ARRDC3 might play a role
in regulating ubiquitination/deubiquitination of the ␤2AR on
endosomes, thereby preventing the receptor from entering the
endosome-lysosomal pathway. Finally, it will also be interesting
to evaluate whether ARRDC3 regulates the degradation of
GPCRs that normally undergo rapid degradation upon endocytosis. Although this remains to be investigated, a recent study
demonstrated that ARRDC3 can regulate the lysosomal sorting
of PAR1 via its ability to promote ubiquitination of ALIX, a
protein that directly binds to some GPCRs to mediate lysosomal sorting (35). Thus, ARRDC3 may have a diverse role in
regulating GPCR sorting.
By actively retaining the ␤2AR on endosomes, ARRDC3 regulates acute ␤2AR-dependent G␣s-mediated cAMP production
in living cells (Fig. 7). It has been recently suggested that location-specific signaling events are able to elicit discrete downstream consequences that are distinct from receptor-mediated
signaling on the plasma membrane. For example, ␤2AR-dependent G␣s-mediated endosome signaling has been shown to specifically modulate the activation of cAMP-dependent genes
(42). It will be interesting to evaluate whether ARRDC3 also
regulates this process and/or has different downstream
consequences.
In summary, we found that ARRDC3 is primarily localized to
early endosomes, where it interacts with and retains internalized ␤2AR, thereby preventing ␤2AR entry into SNX27-occupied endosome tubules. As a result, ARRDC3 delays ␤2AR recycling and modulates ␤2AR-dependent signal transduction on
endosomes.

Experimental Procedures
Reagents—The sense-strand silencing siRNA sequence for
ARRDC3 is 5⬘-CGAAAGAGAUGAUGAUAAU(dTdT)-3⬘.
Antibodies used include the following: rabbit polyclonal
ARRDC3 antibody (Abcam, ab64817, 1:500); mouse monoclonal anti-FLAG威 antibody (clone M1, Sigma, F3040, 1 g/ml,
and clone M2, Sigma, F3165, 1 g/ml); rabbit polyclonal antiFLAG威 antibody (Sigma, F7425, 1:1000); mouse monoclonal
EEA1 antibody (clone 14/EEA1, BD Biosciences, 610456,
1:1000); mouse monoclonal SNX27 antibody (clone 1C6,
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that ARRDC3 localizes to early endosomes by interacting with
the ubiquitin-interacting motifs of HRS and STAM via its polyubiquitinated moieties. Interestingly, the expression level of
ARRDC3 noticeably increased when co-expressed with
STAM-1 (Fig. 2A) suggesting that STAM-1 may regulate the
stability of ARRDC3. Thus, we speculate that the basic residues
on the concave surface of the arrestin domains of ARRDC3
facilitate the membrane localization of ARRDC3 by interacting
with phosphoinositides, although the poly-ubiquitinated moiety of ARRDC3 specifically localizes it to early endosomes by
interacting with the ESCRT-0 complex.
Previous co-immunoprecipitation studies suggested that
ARRDC3 interacts with the ␤2AR (15, 19, 36, 37), and one study
reported that this interaction was agonist-dependent (15). We
used three approaches to assess ARRDC3 interaction with the
␤2AR, co-immunoprecipitation, BRET, and a pulldown assay
using in vitro translated ARRDC3 and purified ␤2AR. Our
results demonstrate that ARRDC3 and the ␤2AR interact in a
ligand-independent manner and our BRET results suggest that
this interaction is direct (Fig. 3). Although the interaction of
these proteins is ligand-independent, there is a clear agonistdependent component to the interaction because agonist-dependent endocytosis of the ␤2AR is required to mediate the
co-localization of the ␤2AR with ARRDC3 as noted previously
by Han et al. (19) (Fig. 4).
Although we know relatively little about how ARRDC3 interacts with the ␤2AR, previous studies identified several basic
residues on the ARRDC3 arrestin-like domains that appear to
contribute to this process (36). Although one might speculate
that ARRDC3 would interact with the ␤2AR in a manner similar
to ␤-arrestin interaction with GPCRs, our results suggest that
the ␤2AR does not need to undergo an agonist-promoted conformational change to interact with ARRDC3. Moreover, computer-modeling studies and sequence comparisons suggest that
ARRDC3 likely does not contain a polar core (12), a region that
is critical for proper interaction of ␤-arrestin with the phosphorylated ␤2AR. Thus, we believe that the interaction
between ARRDC3 and the ␤2AR is not driven by agonist stimulation or by the phosphorylation state of the receptor.
The functional role of ARRDC3 in ␤2AR endocytic trafficking is controversial (15, 19), and the specific mechanism by
which it regulates trafficking has not been elucidated. We found
that ARRDC3 regulates the ␤2AR endosomal residence time
(Fig. 4, E–H) by modulating ␤2AR and SNX27 co-localization
(Fig. 6, A and C) and subsequent entry into endosomal
tubules (Fig. 5B). However, ARRDC3 does not function to regulate ␤2AR endocytosis (Fig. 4, A and B) or degradation (Fig. 4,
C and D). Although it seems likely that ARRDC3 association
with the ESCRT-0 machinery and the ␤2AR may hinder receptor binding to SNX27, we cannot exclude the possible involvement of other proteins in this process. For example, ARRDC2
and ARRDC4 have also been shown to co-localize with the
␤2AR on endosomes (19). Moreover, ARRDC3 has been suggested to homodimerize and heterodimerize with other
ARRDCs and ␤-arrestins (38). Although we did not dissect the
functional roles of other ARRDCs in ␤2AR recycling in this
study, it is possible that they may have additional roles in GPCR
sorting and/or working together with ARRDC3.
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coated opaque 96-well plates (Optiplate, PerkinElmer Life Sciences) at a density of 100,000 cells per well in DMEM with high
glucose (Invitrogen). After 24 h of incubation at 37 °C, cells
were washed three times with PBS ⫹ glucose (Invitrogen), and
2.5 M coelenterazine 400a was added to each well. BRET was
measured at 510 nm following addition of indicated ligands
using a Tecan Infinite F500 microplate reader. BRET ratios ⫽
(light emitted by GFP10)/(light emitted by RLucII). ⌬BRET ⫽
BRET ratio of stimulated trials ⫺ BRET ratio of unstimulated
trials.
Expression and Purification of ␤2AR—The full-length ␤2AR
was cloned into pVL1392 transfer vector for Bestbac expression
system (Expression Systems Inc.). The recombinant baculovirus was used to infect Sf9 cells, and the infected cells were harvested after 48 h of incubation at 27 °C as described previously
(43). Cell pellets were lysed by stirring in lysis buffer (20 mM
HEPES, pH 7.5, 5 mM EDTA, 1 M alprenolol) supplemented
with protease inhibitors (Roche Applied Science) for 30 min.
The receptor was extracted from the cell membrane using
Dounce homogenization in solubilization buffer (20 mM
HEPES, pH 7.5, 100 mM NaCl, 1% dodecyl maltoside, 1 M
alprenolol) supplemented with protease inhibitors for 1 h at
room temperature. After further addition of 2 mM CaCl2, the
solubilized receptor was clarified by high speed centrifugation
at 18,000 ⫻ g for 30 min. The receptor bearing N-terminal
FLAG epitope was captured by M1 antibody affinity chromatography (Sigma) and then eluted with HMS-CHS buffer (20
mM HEPES, pH 7.5, 350 mM NaCl, 0.1% dodecyl maltoside,
0.01% cholesterol hemisuccinate) supplemented with 5 mM
EDTA and 200 g/ml free FLAG peptide. The protein sample
was further purified by affinity chromatography using alprenolol-Sepharose to select functional receptors (44). Size-exclusion chromatography with Superdex-200 column (GE Healthcare) equilibrated in HMS-CHS buffer was used as a final
purification step. The receptor was concentrated to ⬃150 M
and used in subsequent studies. The purity of ␤2AR was ⬎95%
as assessed by SDS-PAGE.
In Vitro Pulldown Assay—Purified ␤2AR (⬃0.8 M) was incubated with 500 M ISO or 400 M propranolol in assay buffer
(20 mM Tris, pH 7.5, 2 5 mM NaCl, 1 mM CaCl2, 0.0001% maltose-neopentyl glycol) for 30 min on ice. The mixture was then
incubated with anti-FLAG M1-agarose beads (Sigma) for 45
min at 4 °C followed by three washes with assay buffer. The
receptor-bound beads were then incubated with in vitro translated 35S-labeled ARRDC3 in assay buffer containing the appropriate ligand for 45 min at 4 °C with rotation, washed three
times with assay buffer, and then incubated with elution buffer
(100 mM glycine, pH 3.5, 0.01% maltose-neopentyl glycol) for 30
min on ice and centrifuged. Supernatant was collected and analyzed by fluorography. In vitro translated 35S-labeled ARRDC3
was generated using TNT威-coupled reticulocyte lysate system
(Promega). AmplifyTM (GE Healthcare) was used to enhance
the fluorographic signal.
Analysis of Receptor Internalization Using Cell Surface
ELISA—48 h post-transfection, FLAG-␤2AR-stable HEK293
cells were serum-starved, stimulated with 10 M ISO for the
indicated times at 37 °C, washed with ice-cold PBS, and fixed
with 4% paraformaldehyde on ice. The amount of remaining
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Abcam, ab77799, 1:500); rabbit polyclonal VPS26 antibody
(Abcam, ab23892, 1:500); rabbit polyclonal STAM antibody
(ProteinTechTM, 12434-1-AP, 1:25 (immunofluorescence),
1:1000 (Western blot)); mouse monoclonal GFP antibody
(Santa Cruz Biotechnology, sc-9996, 1:2000); mouse monoclonal HA.11 antibody (clone 16B12, Covance, MMS-101P,
1:1000); mouse monoclonal ubiquitin antibody (clone P4D1,
Cell Signaling, 3936, 1:1000); mouse monoclonal LAMP1 antibody (clone H4A3, DSHB, 1:1000); and rabbit polyclonal giantin antibody (Covance, PRB-114C, 1:500). mApple-SNX27 was
provided by B. T. Lobingier in the laboratory of M. von Zastrow,
and GFP10-␤-arrestin2 and ␤2AR-RlucII were provided by M.
Bouvier, and FLAG-STAM1 was provided by A. Marchese.
Cell Culture and Transfection—Human embryonic kidney
293 (HEK293) cells were maintained in Dulbecco’s modified
Eagle’s Medium (DMEM) (Fisher) supplemented with 10% fetal
bovine serum (FBS) (Invitrogen) and 10 mM HEPES (Fisher).
FLAG-␤2AR-stable HEK293 cells were maintained in DMEM
supplemented with 10% FBS, 10 mM HEPES, and 500 g/ml
G418 (Fisher). BT549 cells were maintained in RPMI 1640
medium with L-glutamine and 25 mM HEPES (Fisher) supplemented with 10% FBS. HEK293 and BT549 cells grown to
⬃70% confluence in 10-cm plates were transiently transfected
with 6 g of total plasmid DNA using XtremeGene HP (Roche
Applied Science) or 20 nM siRNA using Lipofectamine 2000
(Invitrogen) for 48 h.
Co-immunoprecipitation—48 h post-transfection, cells were
serum-starved for 1 h, stimulated with vehicle or 10 M ISO for
20 min at 37 °C, washed with ice-cold phosphate-buffered
saline (PBS), and then lysed in buffer containing 50 mM TrisHCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 5 mM EDTA, protease inhibitor mixture, and PhosStop tablet (Roche Applied Science). Cells were
sonicated and centrifuged at 3000 rpm for 10 min at 4 °C, and
protein concentrations of the supernatant were determined
using a Bradford protein assay (Bio-Rad). Equal amounts of the
soluble lysate were immunoprecipitated with a polyclonal antiFLAG antibody (Sigma) and protein A-agarose beads (Roche
Applied Science) at 4 °C overnight or at room temperature for
2 h. Immunoprecipitates and total cell lysates were separated by
SDS-PAGE, transferred to nitrocellulose, and immunoblotted
with appropriate antibodies. Immunoblots were incubated
with SuperSignal West Pico reagent (Pierce), exposed to film,
and developed.
To detect polyubiquitinated ARRDC3, cells were lysed in
50 mM HEPES, pH 7.5, 0.5% Nonidet P-40, 250 mM NaCl, 2
mM EDTA, 10% (v/v) glycerol, 1 mM sodium orthovanadate,
1 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 1
mM N-ethylmaleimide, 1 protease inhibitor tablet (Roche
Applied Science), and 1 PhosStop tablet (Roche Applied Science) and centrifuged at 3000 rpm for 10 min at 4 °C. Equal
amounts of the soluble lysate were immunoprecipitated with an
ARRDC3 antibody (Abcam) and protein A-agarose beads
(Roche Applied Science) at 4 °C for 4 h. Samples were washed
three times with lysis buffer, and bound protein was eluted with
2⫻ SDS sample buffer.
Bioluminescence Resonance Energy Transfer (BRET)—24 h posttransfection, cells were plated in poly-L-ornithine (Sigma)-
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numerical aperture (NA) objective under wide-field illumination in Opti-MEM (Invitrogen) supplemented with 10% FBS
and 40 mM HEPES, pH 7.5. Images were collected at 1-min
intervals, and four time points were collected before ISO addition. Cells were stimulated with 10 M ISO for 15 min; ISOcontaining medium was then removed; cells were washed once
with plain medium and medium containing 10 M alprenolol
(Sigma) was added and incubated for 20 min. Measured intensities were background-corrected and normalized to the average of the first four frames.
Fixed-cell Immunofluorescence Microscopy—To assess the
cellular localization of ARRDC3, ␤2AR, and SNX27/VPS26
after agonist washout, FLAG-␤2AR-stable HEK293 cells were
transiently transfected with either pEGFP-ARRDC3 or vector
control. 48 h post-transfection, cells were incubated with M1
anti-FLAG antibody for 20 min to selectively label ␤2AR present in the plasma membrane. Cells were then stimulated with
10 M ISO for 20 min, quickly washed three times with ice-cold
PBS/EDTA, and incubated with 10 M propranolol in DMEM
for the indicated times at 37 °C.
To assess the cellular localization of ARRDC3 and endocytic
markers, cells were transiently transfected with either pEGFPARRDC3/vector control (HEK293 cells) or siARRDC3/siControl (BT549 cells). To study the localization of pEGFPARRDC3, 48 h post-transfection, cells were fixed with 2%
paraformaldehyde (Sigma)/PBS for 10 min at room temperature, washed once with PBS and incubated in blocking buffer
(0.1% Triton X-100, 1% BSA, 10% goat serum, 1 mM CaCl2, PBS)
for 1 h at room temperature. To study the localization of endogenous ARRDC3 in BT549 cells, 48 h post-transfection, cells
were fixed with 3.7% paraformaldehyde/PHEM (60 mM PIPES,
25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 7.2) for 10 min
at room temperature, washed once with PHEM, and incubated
in blocking buffer (0.1% saponin, 10% goat serum, 3% BSA,
PHEM) for 1 h at room temperature. Cells were then probed
with appropriate primary antibodies, washed four times with
0.05% Triton X-100/PBS or 0.05% saponin/PHEM, re-blocked
with appropriate blocking buffer for 30 min at room temperature, and then probed with secondary antibodies for 1 h at room
temperature. After secondary antibody staining, cells were
washed four times and mounted with ProLong Diamond
mounting medium (Invitrogen). Laser-scanning confocal
microscopy was performed using a microscope (LSM510, Carl
Zeiss, Inc.) fitted with a ⫻63/NA 1.4 oil objective lens.
Although the overexpression of ARRDC3 in HEK293 cells
was ⬍10-fold over endogenous levels (data not shown), we
typically only analyzed cells with relatively low amounts
of expressed pEGFP-ARRDC3 for immunofluorescence
microscopy experiments.
Live-cell Imaging—To visualize and analyze ␤2AR-containing endosomal tubules, pEGFP-ARRDC3 was transiently transfected in FLAG-␤2AR-stable HEK293 cells. 48 h post-transfection, surface receptors were labeled by incubating cells with M1
anti-FLAG antibody (Sigma) conjugated to Alexa647 (Invitrogen) for 10 min at 37 °C. Cells were washed once with imaging
media (Opti-MEM supplemented with 10% FBS and 40 mM
HEPES), incubated with 10 M ISO for 10 min at 37 °C, and
then imaged on a Nikon TE-2000E inverted microscope with a
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cell surface FLAG-␤2AR was determined by incubating with
M1 anti-FLAG antibody (Sigma) and washing and incubating
with an HRP-conjugated horse anti-mouse secondary antibody
(Vector Laboratories). After washing, cells were incubated with
one-step ABTS (Pierce); an aliquot was removed, and absorbance at 405 nm was determined.
Analysis of Receptor Internalization Using Flow Cytometry—
48 h post-transfection, FLAG-␤2AR-stable HEK293 cells were
incubated with M1 FLAG antibody conjugated to Alexa647 in
DMEM supplemented with 1 mM CaCl2 for 15 min to label cell
surface FLAG-tagged receptor. Cells were washed once with
DMEM/CaCl2 and then treated with 10 M ISO for 20 min. To
stop the stimulation, cells were placed on ice and washed once
with ice-cold PBS/EDTA. 250 l of ice-cold PBS/EDTA were
added to each sample and shaken at 4 °C for 15 min. Cells were
transferred into tubes and analyzed by flow cytometry.
Receptor Degradation Assay—24 h post-transfection, equal
amounts of cells were plated onto 6-well dishes. The next day,
cells were treated with either vehicle or 10 M (⫺)-isoproterenol in 0.1 mM ascorbic acid for the indicated times. At each time
point, cells were washed four times with PBS, then lysed by
addition of lysis buffer (20 mM Tris-HCl, pH 7.5, 2 mM EGTA, 5
mM EDTA, and 1 complete protease inhibitor tablet (Roche
Applied Science)), and sonicated on ice. Samples were centrifuged in a tabletop centrifuge at 13,000 rpm for 10 min at 4 °C.
Receptor expression was measured in the cell lysate by incubating with 1 nM [125I]iodocyanopindolol (PerkinElmer Life Sciences) ⫾ 10 M propranolol at room temperature for 1 h. Binding reactions were terminated by the addition of 5⫻ 4 ml of
ice-cold wash buffer (25 mM Tris-HCl, pH 7.5, 2 mM MgCl2)
followed by rapid filtration through Whatman GF/C filters
using a Brandel Cell Harvester. [125I]Iodocyanopindolol binding was quantitated by gamma emission counting.
Analysis of Receptor Recycling Using Flow Cytometry—48 h
post-transfection, FLAG-␤2AR-stable HEK293 cells were incubated with M1 FLAG antibody (Sigma) in DMEM supplemented with 1 mM CaCl2 for 15 min to label cell surface FLAGtagged receptors. Cells were washed once with DMEM/CaCl2
and then treated with 10 M ISO for 25 min to drive labeled
␤2AR to steady state in the endocytic pathway (surface labeling
assay). Alternatively, cells were incubated with 10 M ISO plus
M1 FLAG antibody conjugated to Alexa647 (M1 FLAG-Alexa647; 1 g/ml) in DMEM supplemented with 1 mM CaCl2 for
25 min (feeding assay). Any antibody-labeled FLAG-␤2AR
remaining on the cell surface was then stripped by washing the
cells with ice-cold PBS/EDTA three times. Cells were then
treated with 10 M propranolol in DMEM supplemented with 1
mM CaCl2 for the indicated times, placed on ice to stop ␤2AR
trafficking, and removed from the plate with ice-cold staining
buffer (PBS, CaCl2, 1% BSA). Cells were either transferred into
flow cytometry tubes for analysis (feeding assay) or incubated
with anti-mouse-Alexa488 (Molecular Probes) in staining
buffer on ice for 1 h and then washed three times with staining
buffer. The amount of recycled cell surface FLAG-␤2AR at each
time point was measured using a FACSCalibur Flow Cytometer
(BD Biosciences).
Analysis of Receptor Recycling in Living Cells—48 h posttransfection, cells were imaged live at 37 °C with 20 ⫻ 0.75
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